Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 
      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Doxazosin Mesylate
      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
     
   PRODUCT LIST
   Home
   API
   Pharmaceuticals API List >>
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Pharmacokinetic data


















 







 



 
 


Doxazosin Mesylate CAS number 74191-85-8

Doxazosin Mesylate

CAS number 74191-85-8

Structural Formula :
Doxazosin Mesylate Formula C23H25N5O5

Doxazosin Mesylatea quinazoline compoundis an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.

Systematic (IUPAC) name
2-{4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine

Identifiers

CAS number 74191-85-8
ATC code C02CA04
PubChem 3157
DrugBank APRD00474

Chemical data

Formula C23H25N5O5
Mol. mass 451.475 g/mol
Pharmacokinetic data
Bioavailability 65%
Protein binding 98%
Metabolism Hepatic
Half life 22 hours

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj pharmaceuticals API Logo

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

      Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.